{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:42:18Z","timestamp":1789897338504,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral Biology and Craniofacial Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jobcr.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:01:14Z","timestamp":1495670474000},"page":"194-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Research advances in Apert syndrome"],"prefix":"10.1016","volume":"8","author":[{"given":"Satrupa","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jobcr.2017.05.006_bib0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.37549\/AR1274","article-title":"Apert's syndrome","volume":"33","author":"Chonka","year":"2004","journal-title":"Appl Radiol"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0010","series-title":"Craniosynostosis: diagnosis, evaluation, and management","author":"Cohen","year":"2000"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0015","first-page":"321","article-title":"Analysis of phenotypic features and FGFR2 mutations in Apert syndrome","volume":"57","author":"Park","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0020","first-page":"923","article-title":"Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome","volume":"58","author":"Slaney","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0025","article-title":"Clinics in plastic surgery","volume":"vol. 18","year":"1991"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2005.02.003","article-title":"FGF signaling in the developing endochondral skeleton","volume":"16","author":"Ornitz","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0035","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1073\/pnas.121183798","article-title":"Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome","volume":"98","author":"Ibrahimi","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0040","doi-asserted-by":"crossref","first-page":"14536","DOI":"10.1073\/pnas.97.26.14536","article-title":"Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome","volume":"97","author":"Yu","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1399-0004.2000.570208.x","article-title":"Genotype-phenotype analysis in Apert syndrome suggests opposite effects of the two recurrent mutations on syndactyly and outcome of craniofacial surgery","volume":"57","author":"von Gernet","year":"2000","journal-title":"Clin Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1242\/dev.127.3.483","article-title":"An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis","volume":"127","author":"De Moerlooze","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0055","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1242\/dev.129.16.3783","article-title":"The IIIc alternative of Fgfr2 is a positive regulator of bone formation","volume":"129","author":"Eswarakumar","year":"2002","journal-title":"Development"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0060","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1242\/dev.126.24.5611","article-title":"Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault","volume":"126","author":"Iseki","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0065","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gad.990702","article-title":"FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease","volume":"16","author":"Ornitz","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0070","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)80252-4","article-title":"A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras\/MAPK signalling pathway","volume":"89","author":"Kouhara","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0075","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2001-2-3-reviews3005","article-title":"Fibroblast growth factors","author":"Ornitz","year":"2001","journal-title":"Genome Biol"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/1097-4644(20010401)81:1<68::AID-JCB1024>3.0.CO;2-S","article-title":"Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts","volume":"81","author":"Debiais","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0085","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0002-9440(10)64139-9","article-title":"Increased osteoblast apoptosis in Apert craniosynostosis: role of protein kinase C and interleukin-1","volume":"158","author":"Lemonnier","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S8756-3282(03)00222-9","article-title":"A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis","volume":"33","author":"Chen","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0095","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1242\/dev.01914","article-title":"Abnormalities in cartilage and bone development in the Apert syndrome FGFR2 (+\/S252W) mouse","volume":"132","author":"Wang","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bone.2007.11.019","article-title":"A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis","volume":"42","author":"Yin","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ydbio.2009.01.026","article-title":"Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology","volume":"328","author":"Holmes","year":"2009","journal-title":"Dev Biol"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/dvdy.21648","article-title":"Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model","volume":"238","author":"Hajihosseini","year":"2009","journal-title":"Dev Dyn"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0115","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/dvdy.22218","article-title":"Brain phenotypes in two FGFR2 mouse models for Apert syndrome","volume":"239","author":"Aldridge","year":"2010","journal-title":"Dev Dyn"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0120","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1002\/dvdy.22414","article-title":"Beyond the closed suture in apertsyndrome mouse models: evidence of primary effects of FGFR2 signaling onfacial shape at birth","volume":"239","author":"Mart\u00ednez-Abad\u00edas","year":"2010","journal-title":"Dev Dyn"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0125","first-page":"768","article-title":"From shape to cells: mouse models reveal mechanisms altering palate development in Apert syndrome","volume":"6","author":"Mart\u00ednez-Abad\u00edas","year":"2013","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bone.2008.02.008","article-title":"The study of abnormal bone development in the Apert syndrome Fgfr2+\/S252W mouse using a 3D hydrogel culture model","volume":"43","author":"Yang","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng0295-165","article-title":"Apert syndrome results from localized mutations of FGFR2 and allelic with Crouzon syndrome","volume":"9","author":"Wilkie","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0140","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1086\/302245","article-title":"De novo Alu- element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome","volume":"64","author":"Oldridge","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0145","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1597\/1545-1569_2002_039_0332_tpoacp_2.0.co_2","article-title":"Toward pathogenesis of Apert cleft palate: FGF, FGFR, and TGF beta genes are differentially expressed in sequential stages of human palatal shelf fusion","volume":"39","author":"Britto","year":"2002","journal-title":"Cleft Palate Craniofac J"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0150","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2119\/2007-00027.Fanganiello","article-title":"Apert p.Ser252Trp mutation in FGFR2 alters osteogenic potential and gene expression of cranial periosteal cells","volume":"13","author":"Fanganiello","year":"2007","journal-title":"Mol Med"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0155","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1203\/PDR.0b013e3181b45580","article-title":"Fibroblast growth factor 10 plays a causative role in the tracheal cartilage defects in a mouse model of Apert syndrome","volume":"66","author":"Tiozzo","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0160","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/humu.20825","article-title":"Rare mutations of FGFR2 causing apert syndrome: identification of the first partial gene deletion, and an Alu element insertion from a new subfamily","volume":"30","author":"Bochukova","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2350-12-122","article-title":"A deletion of FGFR2 creating a chimeric IIIb\/IIIc exon in a child with Apert syndrome","volume":"12","author":"Fenwick","year":"2011","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/BJ20100884","article-title":"Identification and characterization of an inhibitory fibroblast growth factor receptor 2 (FGFR2) molecule up-regulated in an Apert Syndrome mouse model","volume":"436","author":"Wheldon","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0175","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.bone.2010.11.014","article-title":"The primary site of the acrocephalic feature in Apert Syndrome is a dwarf cranial base with accelerated chondrocytic differentiation due to aberrant activation of the FGFR2 signalling","volume":"48","author":"Nagata","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0180","doi-asserted-by":"crossref","first-page":"e101693","DOI":"10.1371\/journal.pone.0101693","article-title":"Therapeutic effect of nanogel based delivery of soluble FGFR2 with S252W mutation on craniosynostosis","volume":"9","author":"Yokota","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0185","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/dvdy.24099","article-title":"Soluble form of FGFR2 with S252W partially prevents craniosynostosis of the apert mouse model","volume":"243","author":"Morita","year":"2014","journal-title":"Dev Dyn"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0190","first-page":"115","article-title":"The molecular and cellular basis of Apert syndrome","volume":"2","author":"Liu","year":"2013","journal-title":"Intractable rare Dis Res"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0195","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/hmg\/7.9.1475","article-title":"Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity forFGF ligand","volume":"7","author":"Anderson","year":"1988","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0200","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s004410051374","article-title":"Differential in vitro phenotype pattern, transforming growth factor-beta(1) activity and mRNA expression of transforming growth factor-beta(1) in Apert osteoblasts","volume":"297","author":"Locci","year":"1999","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0205","doi-asserted-by":"crossref","first-page":"14536","DOI":"10.1073\/pnas.97.26.14536","article-title":"Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome","volume":"97","author":"Yu","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0210","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1073\/pnas.071586898","article-title":"A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert\/Pfeiffer-syndrome-like phenotypes","volume":"98","author":"Hajihosseini","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0215","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1359\/jbmr.2001.16.5.832","article-title":"Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis","volume":"16","author":"Lemonnier","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0220","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1359\/jbmr.2001.16.4.705","article-title":"Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray","volume":"16","author":"Lomri","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0225","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/hmg\/ddh235","article-title":"Biochemical analysis of pathogenic liganddependent FGFR2 mutations suggests distinct pathophysiologicalmechanisms for craniofacial and limb abnormalities","volume":"13","author":"Ibrahimi","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0230","doi-asserted-by":"crossref","first-page":"45926","DOI":"10.1074\/jbc.M404824200","article-title":"A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome","volume":"279","author":"Tanimoto","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0235","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1074\/jbc.M512932200","article-title":"Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans","volume":"281","author":"McDowell","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/BJ20071594","article-title":"Extracellular point mutations in FGFR2 elicit unexpected changes in intracellular signalling","volume":"413","author":"Ahmed","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-213X-10-22","article-title":"Activation of p38 MAPK pathway inthe skull abnormalities of Apert syndrome Fgfr2 (+P253R) mice","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Dev Biol"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0250","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ng2096","article-title":"RNA interference and inhibition of MEK-ERK signalling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis","volume":"39","author":"Shukla","year":"2007","journal-title":"Nature Genetics"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0255","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/hmg\/ddq045","article-title":"Increased EFG- and PDGF alpha receptor signaling by mutant FGFreceptor 2 contributes to osteoblastdysfunction in Apert craniosynostosis","volume":"19","author":"Miraoui","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0260","doi-asserted-by":"crossref","first-page":"e26425","DOI":"10.1371\/journal.pone.0026425","article-title":"FGF\/FGFR signaling coordinates skull development by modulating magnitude of morphological integration: evidence from Apert syndrome mouse models","volume":"6","author":"Mart\u00ednez-Abad\u00edas","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0265","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ydbio.2012.05.026","article-title":"Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome","volume":"368","author":"Holmes","year":"2012","journal-title":"Dev Biol"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0270","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1002\/jcp.24021","article-title":"Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts","volume":"227","author":"Suzuki","year":"2012","journal-title":"J Cell Physiol"},{"issue":"8","key":"10.1016\/j.jobcr.2017.05.006_bib0275","doi-asserted-by":"crossref","first-page":"e60439","DOI":"10.1371\/journal.pone.0060439","article-title":"Novel molecular pathways elicited by mutant FGFR2 may account for brain abnormalities in Apert syndrome","volume":"2013","author":"Yeh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0280","doi-asserted-by":"crossref","first-page":"e87311","DOI":"10.1371\/journal.pone.0087311","article-title":"A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome revealsan essential role for FGF signaling inthe regulation of endochondral bone formation","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0285","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2014.03.003","article-title":"Morphological comparison ofthe craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252Wmutation in neural crest- or mesoderm-derived tissues","volume":"63","author":"Heuz\u00e9","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0290","doi-asserted-by":"crossref","first-page":"e112716","DOI":"10.1371\/journal.pone.0112716","article-title":"Inhibited Wnt signaling causes age-dependent abnormalities in the bone matrix mineralization in the Apert syndrome FGFR2(S252W\/+) mice","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0295","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/(SICI)1096-8628(19971112)72:4<394::AID-AJMG4>3.0.CO;2-R","article-title":"Birth prevalence, mutation rate, sex ratio, parents\u2019 age, and ethnicity in Apert syndrome","volume":"72","author":"Tolarova","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0300","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1601-6343.2007.00389.x","article-title":"Syndromic craniosynostosis: from history to hydrogen bonds","volume":"10","author":"Cunningham","year":"2007","journal-title":"Orthod Craniofac Res"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0305","first-page":"733","article-title":"S252W mutation in Indian patients of Apert syndrome","volume":"43","author":"Girisha","year":"2006","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0310","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.11622\/smedj.2013055","article-title":"p.Ser252Trp and p. Pro253Arg mutations in FGFR2 gene causing Apert syndrome: the first clinical and molecular report of Indonesian patients","volume":"54","author":"Mundhofir","year":"2013","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0315","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.4238\/2015.March.27.19","article-title":"Mutations in the FGFR2 gene in Mexican patients with Apert syndrome","volume":"14","author":"Ibarra-Arce","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0320","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ng0596-48","article-title":"Exclusive paternal origin of new mutations in Apert syndrome","volume":"13","author":"Moloney","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0325","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/302831","article-title":"Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome","volume":"66","author":"Glaser","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jobcr.2017.05.006_bib0330","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00381-012-1872-z","article-title":"Mouse models of Apert syndrome","volume":"28","author":"Holmes","year":"2012","journal-title":"Childs Nerv Syst"}],"container-title":["Journal of Oral Biology and Craniofacial Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212426817300209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212426817300209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:25:10Z","timestamp":1761945910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212426817300209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2212426817300209"],"URL":"https:\/\/doi.org\/10.1016\/j.jobcr.2017.05.006","relation":{},"ISSN":["2212-4268"],"issn-type":[{"value":"2212-4268","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research advances in Apert syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral Biology and Craniofacial Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jobcr.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Craniofacial Research Foundation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}